Biomerica/$BMRA
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Biomerica
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.
- Ticker
- $BMRA
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 50
- Headquarters
- Irvine, United States
- Website
- www.biomerica.com
Biomerica Metrics
BasicAdvanced
$6.9M
-
-$1.63
0.38
-
Price and volume
Market cap
$6.9M
Beta
0.38
52-week high
$2.94
52-week low
$1.45
Average daily volume
11K
Financial strength
Current ratio
1.907
Quick ratio
1.28
Long term debt to equity
0.435
Total debt to equity
0.638
Profitability
EBITDA (TTM)
-5.357
Gross margin (TTM)
0.95%
Net profit margin (TTM)
-115.47%
Operating margin (TTM)
-125.15%
Effective tax rate (TTM)
-0.52%
Revenue per employee (TTM)
$90,000
Management effectiveness
Return on assets (TTM)
-45.47%
Return on equity (TTM)
-113.80%
Valuation
Price to revenue (TTM)
1.072
Price to book
1.9
Price to tangible book (TTM)
2.02
Price to free cash flow (TTM)
-1.175
Free cash flow yield (TTM)
-85.08%
Free cash flow per share (TTM)
-1.285
Growth
Revenue change (TTM)
-11.18%
Earnings per share change (TTM)
8.23%
3-year revenue growth (CAGR)
-7.13%
10-year revenue growth (CAGR)
-1.91%
3-year earnings per share growth (CAGR)
-20.90%
10-year earnings per share growth (CAGR)
0.32%
Biomerica Financial Performance
Revenues and expenses
Biomerica Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.